指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

胃肠道内镜镇静:欧洲胃肠道内镜学会(ESGE)与欧洲胃肠病和内镜护士协会(ESGENA)指南

Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline.
指南 / 共识 · Endoscopy · 2026-07-21
一句话结论ESGE与ESGENA推荐胃肠内镜镇静应由专职受过培训的医护人员实施,丙泊酚为首选,高风险患者需加强围术期监测。

该指南由ESGE与ESGENA制定,针对胃肠道内镜镇静的知情同意、术前评估、镇静方案、监测、恢复和特殊情况(如急诊内镜、妊娠、GLP-1受体激动剂使用者)提出推荐。推荐包括:知情同意应涵盖镇静;高风险患者需预评估、特定镇静方案和加强围术期监测;镇静应由专职受训人员提供;丙泊酚为一线镇静药,需镇痛时咪达唑仑联合阿片类;老年及心血管/呼吸合并症患者可考虑瑞马唑仑;高危低氧血症患者建议二氧化碳监测;拮抗剂仅用于非药物干预无效的镇静镇痛不良事件;急诊内镜在血流动力学稳定患者中可在中度镇静下进行,误吸风险高或血流动力学不稳定或严重合并症者应由麻醉专科医师实施镇静。证据确定性多为极低,推荐强度多为强推荐。

要点

  • ESGE与ESGENA推荐胃肠道内镜镇静应由专职受过镇静给药和患者监测培训的医护人员提供(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐丙泊酚作为程序镇静一线药物,需镇痛时咪达唑仑联合阿片类(强推荐,证据确定性极低)。
  • ESGE与ESGENA建议对低氧血症风险较高的镇静胃肠内镜患者使用二氧化碳监测(条件推荐,证据确定性极低)。
  • ESGE与ESGENA推荐急诊内镜在血流动力学稳定患者中于中度镇静下进行;误吸风险增加、血流动力学不稳定或严重合并症者应由麻醉专科医师实施镇静(强推荐,证据确定性极低)。
  • ESGE与ESGENA建议老年及心血管和/或呼吸合并症患者可考虑超短效镇静药瑞马唑仑(条件推荐,证据确定性低)。

适用人群与场景

  • 接受胃肠道内镜诊疗并需要镇静的患者,包括高风险患者(需预评估、特定镇静方案和加强围术期监测)。
  • 老年患者及有心血管和/或呼吸合并症的患者可考虑瑞马唑仑。
  • 使用胰高血糖素样肽-1受体激动剂的患者,镇静管理应个体化。
  • 妊娠患者接受胃肠道内镜时,镇静的适宜性和选择应与参与其照护的麻醉和产科团队协商,并结合患者意愿。
  • 急诊内镜患者:血流动力学稳定者可在中度镇静下进行;配合的患者也可选择无镇静;误吸风险增加、血流动力学不稳定或严重合并症者应由麻醉专科医师实施镇静。

处置流程与药物剂量

  • ESGE与ESGENA推荐胃肠道内镜程序的知情同意应包括对镇静的同意,并涵盖ESGE知情同意立场声明中概述的最佳实践(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐高风险患者接受胃肠道内镜镇静时进行预评估、采用特定镇静方案并加强围术期监测,以降低镇静相关不良事件风险(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐预评估、镇静方案和围术期监测应根据内镜操作的复杂性(持续时间、侵入性)确定(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐镇静应由专职受过镇静给药和患者监测培训的医护人员提供(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐丙泊酚作为程序镇静一线药物,具体取决于各国人力资源、服务框架和法规;需要镇痛时推荐咪达唑仑联合阿片类药物(强推荐,证据确定性极低)。
  • ESGE与ESGENA建议老年患者及有心血管和/或呼吸合并症的患者可考虑使用超短效镇静药瑞马唑仑(条件推荐,证据确定性低);建议将超短效镇静药与其他镇静药或镇痛药联合使用时需谨慎(条件推荐,证据确定性低)。
  • ESGE与ESGENA建议对低氧血症风险较高的镇静胃肠内镜患者使用二氧化碳监测(条件推荐,证据确定性极低)。
  • ESGE与ESGENA推荐拮抗剂的使用应限于处理非药物干预无效的镇静镇痛不良事件(强推荐,证据确定性极低);推荐内镜后由受过培训的合格人员监测患者直至恢复基线观察指标(强推荐,证据确定性极低)。

红旗征与不能漏的情况

  • 急诊内镜患者若误吸风险增加、血流动力学不稳定或存在严重合并症,应由麻醉专科医师实施镇静(强推荐,证据确定性极低)。
  • 镇静镇痛不良事件经非药物干预无效时,才应使用拮抗剂(强推荐,证据确定性极低)。

研究设计与关键结果

  • ESGE与ESGENA制定本指南,共提出多条推荐,证据确定性多为极低,推荐强度多为强推荐;涉及知情同意、预评估与监测、镇静方案、监测技术、拮抗剂使用、恢复与出院、急诊内镜、妊娠及培训与质量改进。

证据类型、等级与局限

  • 证据类型:指南;推荐强度与证据确定性照录原文(强推荐,证据确定性极低;条件推荐,证据确定性低;强推荐,证据确定性中等)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ESGE与ESGENA推荐胃肠内镜镇静由专职受过培训的医护人员实施,而不是由操作内镜医师独自承担镇静(强推荐,证据确定性极低)。
  • ESGE与ESGENA推荐丙泊酚作为程序镇静一线药物,需镇痛时咪达唑仑联合阿片类(强推荐,证据确定性极低);具体选择需考虑各国人力资源、服务框架和法规。
  • ESGE与ESGENA建议对低氧血症风险较高的镇静胃肠内镜患者使用二氧化碳监测(条件推荐,证据确定性极低)。
  • ESGE与ESGENA建议老年及心血管和/或呼吸合并症患者可考虑瑞马唑仑(条件推荐,证据确定性低),并建议超短效镇静药与其他镇静药或镇痛药联合使用时需谨慎(条件推荐,证据确定性低)。
  • ESGE与ESGENA推荐急诊内镜在血流动力学稳定患者中于中度镇静下进行,配合的患者也可无镇静;误吸风险增加、血流动力学不稳定或严重合并症者应由麻醉专科医师实施镇静(强推荐,证据确定性极低)。
  • ESGE与ESGENA建议使用评分系统和标准化出院核对表评估出院准备,包括生命体征、疼痛水平和精神运动表现(条件推荐,证据确定性极低);推荐出院时有人陪同(强推荐,证据确定性极低)。

指南或共识出处

  • 欧洲胃肠道内镜学会(ESGE)与欧洲胃肠病和内镜护士协会(ESGENA)指南:胃肠道内镜镇静。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that informed consent for gastrointestinal endoscopic procedures should include consent for sedation and cover best practice as outlined in the ESGE Position Statement for informed consent.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend pre-assessment, a specific sedation regimen, and enhanced periprocedural monitoring in high-risk patients undergoing gastrointestinal procedures with sedation, to reduce the risk of sedation-related adverse events.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that pre-assessment, sedation regimen, and periprocedural monitoring should be determined by the complexity (duration, invasiveness) of the endoscopic procedure.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest that the management of sedation in patients on glucagon-like peptide-1 receptor agonists should be individualized. Conditional recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest offering the option of diagnostic colonoscopy and gastroscopy without sedation, based on the patient's and endoscopist's preference.Conditional recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that sedation should be provided by a dedicated healthcare professional trained in sedation administration and patient monitoring.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend propofol for procedural sedation, as first line, depending on the country's human resources, service framework, and legislation.ESGE and ESGENA recommend midazolam for procedural sedation, in combination with opiates when analgesia is required.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest the provision of the ultrashort-acting sedative remimazolam in elderly patients and patients with cardiovascular and/or respiratory comorbidities.Conditional recommendation, low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest exercising caution when combining ultrashort-acting sedatives with other sedatives or analgesics.Conditional recommendation, low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest capnography monitoring for patients undergoing sedated gastrointestinal endoscopy who are at higher risk of hypoxemia.Conditional recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that the use of reversal agents should be restricted to managing sedation-analgesia adverse events that do not improve with nonpharmacological intervention.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that patients be monitored after endoscopy by trained and qualified staff until the return of the patient's baseline observations.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest using scoring systems and standardized discharge checklists to facilitate patient readiness for discharge. Assessments should include a detailed record of vital signs, pain levels, and psychomotor performance.Conditional recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA suggest that the performing endoscopist holds the overall medicolegal responsibility for the patient's treatment, including safe recovery, but may delegate the assessment and discharge to trained and qualified personnel based on standardized discharge criteria.Conditional recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend that patients receive oral and written information regarding the post-endoscopy period. Contact details should be provided for potential delayed complications, emergencies, or readmission.ESGE and ESGENA recommend that patients undergoing sedated endoscopy have an accompanying person at discharge.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend performing emergency endoscopy under moderate sedation in hemodynamically stable patients. Alternatively, emergency endoscopy without sedation in cooperative patients is feasible.ESGE and ESGENA recommend sedation administration by an anesthesiology specialist in emergency endoscopy in patients at increased risk of aspiration, or with hemodynamic instability or significant comorbidities.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend consultation with anesthetic and obstetric teams involved in the pregnant patient`s care, together with the patient's choice for the appropriateness and choice of sedation during gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend improving and expanding educational offerings on sedation strategies and the principles of airway management, using structured training.Strong recommendation, low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend the development and implementation of a quality improvement program with performance indicators to monitor the quality of sedation practices in gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence.

MAIN RECOMMENDATIONS: ESGE and ESGENA recommend a rational use of sedatives to reduce the environmental impact of endoscopy.Strong recommendation, moderate certainty of evidence.

来源:Endoscopy,查看原文。版权归原作者所有。

参考来源

  1. Triantafyllou K, Tziatzios G, Tham TC, et al. Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline. Endoscopy. 2026. PMID: 42480549. doi:10.1055/a-2898-6540

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。